Insider Transactions Reported by 20 Insiders of Generation Bio Co.

Symbol
GBIO on Nasdaq
Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 16 Feb 2025

Generation Bio Co. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew Stanton Chief Scientific Officer $1,372,339 10 Jan 2025
Matthew Norkunas Chief Financial Officer $880,215 10 Jan 2025
Phillip Samayoa Chief Scientific Officer $835,200 31 Oct 2025
Antoinette Paone Chief Operating Officer $766,026 31 Oct 2025
Douglas Kerr Chief Medical Officer $732,693 29 Jan 2024
Charles A. Rowland Jr Director $275,400 09 Feb 2026
Gustav Christensen Director $275,400 09 Feb 2026
Jason P. Rhodes Director $275,400 09 Feb 2026
Dannielle Appelhans Director $275,400 09 Feb 2026
Donald William Nicholson Director $275,400 09 Feb 2026
Ronald Harold Wilfred Cooper Director $275,400 09 Feb 2026
Catherine Stehman-Breen Director $275,400 09 Feb 2026
JEFFREY M. JONAS Director $275,400 09 Feb 2026
Anthony G. Quinn Director $275,400 09 Feb 2026
Tracy Zimmermann Chief Development Officer $93,412 29 Jan 2024
GEOFF MCDONOUGH Director $13,576 09 Feb 2026
Yalonda Howze Interim Ceo And President $9,847 09 Feb 2026
Kevin John Conway Chief Financial Officer $3,647 09 Feb 2026
ATLAS VENTURE ASSOCIATES X, L.P. 10%+ Owner $1,161 27 Sep 2021
Atlas Venture Fund X, L.P. 10%+ Owner $0 09 Feb 2026

Recent Insider Transactions by Companies or Individuals for Generation Bio Co.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.